So the question is not only: where do resident macrophages come from? It is also: when does self-maintenance become durable, and when does it fail to do so? That is the problem Establishment Kinetics is meant to solve. Full paper in Advances in Immunology sciencedirect.com/science/ch…
Super excited to participate to Global Immunotalks on Wednesday November 25. Absolutely honored to be in this list of fantastic speakers over the years. Join us live in 10 days for a talk on decoding the causal circuits controlling resident macrophage function in health & disease
Our review is out in @TrendsImmuno
“From Tissue Adaptation to Disease-Associated Eosinophil States” explores how disease reshapes eosinophil identity and function—and why looking beyond cell counts matters for therapy. authors.elsevier.com/a/1o3ht…
🧙🏽♀️ Spooky season is over, but it’s a great time to celebrate the everyday magic of #science! Learn about the healing power of stem cells & the #HarryPotter-esque work of our @ShiriGurCohen & Karl Willert, who were recently awarded a $2.5M @CIRMnews grant: bit.ly/4BBWbHf.
Thank you to the Donald K. Johnson Eye Institute for a wonderful visit and the honor of giving the first keynote. A great reminder of how deeply intertwined Canadian and US science are: we train each other's students, build on each other's discoveries, and are stronger together.
👏 Dr. Daniel Saban @DukeU joined us today as our first keynote speaker.
His talk explored the often overlooked role of immune cells in maintaining ocular health and resilience, highlighting how the immune system contributes to protecting the eye and responding to injury and disease.
#VisionResearch#NoResearchNoCure
What comes after M1/M2? In our Perspective with @FGinhoux in @ImmunityCP we explore how single-cell technologies and AI can decode the gene programs macrophages use across tissues & microenvironments, and how this modular view could transform immunotherapy
cell.com/immunity/abstract/S…
🪄Regeneration is a conversation between stem cells and their surroundings. 🥳I’m excited to share our new review on the expanding landscape of stem cell niches and how understanding stem cell–niche dialogue could advance tissue repair and healthy aging 💪🏽
sciencedirect.com/science/ar…
This has been an exciting journey, and our paper is finally out as a preprint! Together with @chihyaochung and in collaboration with Agnel Sfeir, we developed mtDIVE to explore the functional consequences of thousands of mitochondrial DNA variants biorxiv.org/content/10.64898…
1/12
📢 To everyone on the job market who has a vision for neuroscience applied to biomedical applications & technological innovation:
The Duke Dept. of Biomedical Engineering announces a tenure-track faculty job search in neural engineering, broadly defined!
academicjobsonline.org/ajo/j…
New dates, same ReThink spirit! 🏄
Join us at Weizmann, May 24–26, 2027, for 3 days of bold ideas and lively discussions shaping the future of neuroimmunology. Explore our speakers and register: conferences.weizmann.ac.il/R…#ReThinkNeuroimmunology
One unsolicited piece of advice for new #gradstudents. Don't settle on ALL of your #rotations before school starts. Use the first semester to explore. Talk to people! Check out labs and areas that you haven't considered! Go outside of your comfort zone! Let yourself be surprised!
a 427-sample single-cell atlas of multiple myeloma across 341 individuals, linked to genetics and detailed clinical data. Very exciting study by @IdoAmitLab and Co !
Does scale limit what we can discover?
In our new @NatureGenet study, led by @MorZada3 & @Anna_Kurilovich, we built a 427-sample single-cell atlas of multiple myeloma across 341 individuals, linked to genetics and detailed clinical data 🧵 (1/15)
🔗 nature.com/articles/s41588-0…